These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8641213)

  • 1. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y; Chokki M; Ohta T; Kiyoki M
    Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in urinary excretion of deoxypyridinoline in tail-suspended rats: effects of a bisphosphonate, YH529.
    Ohmori S; Kurokouchi K; Kanda K; Kawano S; Ito T; Inazu M; Kambe F; Seo H
    Environ Med; 1998 Oct; 42(1):11-3. PubMed ID: 12212616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
    Body JJ; Delmas PD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat.
    Egger CD; Mühlbauer RC; Felix R; Delmas PD; Marks SC; Fleisch H
    J Bone Miner Res; 1994 Aug; 9(8):1211-9. PubMed ID: 7976504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effect of elcatonin, an eel calcitonin analogue, on excessive urinary hydroxyproline excretion in polyostotic fibrous dysplasia (McCune-Albright's syndrome).
    Yamamoto K; Maeyama I; Kishimoto H; Morio Y; Harada Y; Ishitobi K; Ishikawa J
    Endocrinol Jpn; 1983 Oct; 30(5):651-6. PubMed ID: 6423374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of elcatonin on experimental osteoporosis induced by ovariectomy and low calcium diet in beagles].
    Hori M; Takahashi H; Konno T; Inoue J; Haba T; Sakurada T; Noda T; Fujimoto K
    Nihon Yakurigaku Zasshi; 1984 Jul; 84(1):91-8. PubMed ID: 6489866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.
    Gur A; Colpan L; Cevik R; Nas K; Jale Sarac A
    Clin Biochem; 2005 Jan; 38(1):66-72. PubMed ID: 15607319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.
    Altundal H; Sayrak H; Yurtsever E; Göker K
    J Oral Maxillofac Surg; 2007 Mar; 65(3):508-16. PubMed ID: 17307600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
    McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
    Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antiresorptive activities of ipriflavone, an isoflavone derivative, and elcatonin, an eel carbocalcitonin.
    Fujita T; Fujii Y; Miyauchi A; Takagi Y
    J Bone Miner Metab; 1999; 17(4):289-95. PubMed ID: 10575594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of eel calcitonin derivative (elcatonin) in osteoporosis].
    Yoshikawa S; Shiba M; Hoshino T; Igarashi M; Orimo H; Sakuma A; Tsuyama N
    Nihon Seikeigeka Gakkai Zasshi; 1983 Nov; 57(11):1717-28. PubMed ID: 6676389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diurnal rhythm of bone resorption in the rat. Effect of feeding habits and pharmacological inhibitors.
    Mühlbauer RC; Fleisch H
    J Clin Invest; 1995 Apr; 95(4):1933-40. PubMed ID: 7706501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats.
    Aoki M; Mori A; Nakahara T; Sakamoto K; Ishii K
    Eur J Pharmacol; 2012 Dec; 696(1-3):62-9. PubMed ID: 23001015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of bisphosphonates on new and traditional markers of bone resorption.
    Pedrazzoni M; Alfano FS; Gatti C; Fantuzzi M; Girasole G; Campanini C; Basini G; Passeri M
    Calcif Tissue Int; 1995 Jul; 57(1):25-9. PubMed ID: 7671161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women.
    Schlemmer A; Hassager C; Jensen SB; Christiansen C
    J Clin Endocrinol Metab; 1992 Mar; 74(3):476-80. PubMed ID: 1740479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women.
    Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE
    Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared.
    Bettica P; Bevilacqua M; Vago T; Masino M; Cucinotta E; Norbiato G
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3034-9. PubMed ID: 9284739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.